HC Wainwright & Co. Reiterates Longboard Pharmaceuticals (LBPH) Buy Recommendation
Fintel reports that on May 12, 2023, HC Wainwright & Co. reiterated coverage of Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy recommendation. Analyst Price Forecast Suggests 95.93% Upside As of May 11, 2023, the average one-year price target for Longboard Pharmaceuticals is 17.08. The forecasts range from a low of 11.11…
bubmagMay 13, 2023